Endurant Capital Management’s Pfizer PFE Stock Holding History

Endurant Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,790	Closed	-$455K	–	17
2023 Q4	$455K	Buy	+15,790	New	+$477K	2.61%	13
2023 Q2	–	Sell	-73,265	Closed	-$2.99M	–	52
2023 Q1	$2.99M	Buy	+73,265	New	+$3.16M	1.54%	18
2020 Q2	–	Sell	-537,698	Closed	-$16.7M	–	71
2020 Q1	$16.7M	Buy	+537,698	New	+$18.3M	7.55%	2
2018 Q4	–	Sell	-97,379	Closed	-$4.07M	–	71
2018 Q3	$4.07M	Buy	97,379 +61,383	+171%	+$2.36M	1.81%	23
2018 Q2	$1.24M	Buy	+35,996	New	+$1.23M	0.54%	43
2017 Q4	–	Sell	-239,594	Closed	-$8.12M	–	87
2017 Q3	$8.12M	Sell	239,594 -4,302	-2%	-$138K	2.46%	12
2017 Q2	$7.77M	Buy	243,896 +11,489	+5%	+$362K	2.2%	21
2017 Q1	$7.54M	Buy	232,407 +85,796	+59%	+$2.71M	2.43%	14
2016 Q4	$4.52M	Buy	+146,611	New	+$4.48M	1.87%	22
2016 Q3	–	Sell	-33,833	Closed	-$1.13M	–	102
2016 Q2	$1.13M	Sell	33,833 -113,411	-77%	-$3.62M	0.38%	52
2016 Q1	$4.14M	Buy	147,244 +10,962	+8%	+$313K	1.34%	31
2015 Q4	$4.17M	Buy	+136,282	New	+$4.29M	1.4%	28
2015 Q1	–	Sell	-42,582	Closed	-$1.26M	–	101
2014 Q4	$1.26M	Buy	+42,582	New	+$1.22M	0.49%	57

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Endurant Capital Management's PFE Position: Q1 2024 in Review

Endurant Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 15,790 shares — an estimated $455K sold.

Endurant Capital Management first reported a position in PFE in Q4 2014 and held it in 13 quarters. The position peaked at $16.7M in Q1 2020. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Endurant Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Endurant Capital Management sold 15,790 Pfizer shares in Q1 2024, an estimated $455K.
Endurant Capital Management first reported a position in Pfizer in Q4 2014 and held it in 13 quarters.
Endurant Capital Management's Pfizer position peaked at $16.7M in Q1 2020.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Endurant Capital Management's 13F filing for Q1 2024.